FlowCAT offers flexible fixed-bed hydrogenation
Bench-top reactor produces results from millilitres of product
HEL, headquartered in Borehamwood, Hertfordshire, UK, has developed a system that delivers high-pressure flow chemistry, with the flexibility to tune hydrogenation conditions to suit the chemistry.
The system design allows for rapid screening of process conditions, which is useful in the early stage generation of API intermediates, where the behaviour and chemistry of the species may be an unknown.
The FlowCAT system is capable of producing results from just a few millilitres of product, but retains the ability to ramp up production volumes once ideal conditions are identified.
At the heart of the system is a tubular reactor with a standard 3mL or 12mL isothermal reaction zone. The system operates up to 400°C and 200Bar. Any heterogeneous catalyst can be used and users can pack their own columns. The wide-bore reactor removes any propensity for blockages and further extends the reliability of the system, the company says.
You may also like
Trending Articles
Upcoming event
You may also like
Manufacturing
Nulogy launches Supplier Compliance Management to build stronger, more resilient supplier networks
Nulogy, a leading provider of manufacturing operations software, announced the launch of Nulogy Supplier Compliance Management, a solution designed to centralise and automate supplier compliance for procurement, supply chain, and quality assurance teams in manufacturing, food & beverage, pharmaceuticals, and
other highly regulated industries
Manufacturing
AQUARIA - enhancing drying performance while reducing consumption
AQUARIA stands out within the diverse range of parts washers for the pharmaceutical industry that have been developed by IMA over the last two decades. Designed to ensure maximum performance in cleaning and validation with high efficiency, AQUARIA is renowned for its reduced consumption of energy, water, detergents and compressed air. These qualities match the pharmaceutical industry’s current attention to environmental issues and prove how IMA is actively supporting sustainability across a wide spectrum of processes, where its solutions represent a respected benchmark
Manufacturing
Clariant opens first US pharmaceutical-grade PEG excipient manufacturing site in Texas
Clariant has expanded its Clear Lake facility in Texas to produce GMP-compliant pharmaceutical-grade polyethylene glycol excipients, marking its first US-based manufacturing site for the products and strengthening supply chain resilience for North American and Latin American pharma customers